vs
Side-by-side financial comparison of OPEN TEXT CORP (OTEX) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
OPEN TEXT CORP is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× PERRIGO Co plc). OPEN TEXT CORP runs the higher net margin — 12.7% vs -127.8%, a 140.5% gap on every dollar of revenue. On growth, OPEN TEXT CORP posted the faster year-over-year revenue change (-0.6% vs -2.5%). OPEN TEXT CORP produced more free cash flow last quarter ($279.4M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -4.3%).
Open Text Corporation is a global software company that develops and sells information management software.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
OTEX vs PRGO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $168.1M | $-1.4B |
| Gross Margin | 74.0% | 32.6% |
| Operating Margin | 22.0% | -116.0% |
| Net Margin | 12.7% | -127.8% |
| Revenue YoY | -0.6% | -2.5% |
| Net Profit YoY | -26.9% | -3093.9% |
| EPS (diluted) | $0.66 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.4B | $1.1B |
| Q4 25 | $168.1M | $-1.4B | ||
| Q3 25 | $146.6M | $7.5M | ||
| Q2 25 | $28.8M | $-8.4M | ||
| Q1 25 | $92.8M | $-6.4M | ||
| Q4 24 | $229.9M | $-44.4M | ||
| Q3 24 | $84.4M | $-21.0M | ||
| Q2 24 | $248.2M | $-108.4M | ||
| Q1 24 | $98.3M | $2.0M |
| Q4 25 | 74.0% | 32.6% | ||
| Q3 25 | 72.8% | 36.1% | ||
| Q2 25 | 72.3% | 34.4% | ||
| Q1 25 | 71.6% | 37.6% | ||
| Q4 24 | 73.3% | 33.9% | ||
| Q3 24 | 71.7% | 37.2% | ||
| Q2 24 | 72.5% | 37.0% | ||
| Q1 24 | 73.0% | 33.1% |
| Q4 25 | 22.0% | -116.0% | ||
| Q3 25 | 21.0% | 7.0% | ||
| Q2 25 | 13.9% | 4.3% | ||
| Q1 25 | 16.7% | 4.5% | ||
| Q4 24 | 22.2% | 10.0% | ||
| Q3 24 | 16.3% | 7.4% | ||
| Q2 24 | 14.2% | -2.5% | ||
| Q1 24 | 15.7% | -5.1% |
| Q4 25 | 12.7% | -127.8% | ||
| Q3 25 | 11.4% | 0.7% | ||
| Q2 25 | 2.2% | -0.8% | ||
| Q1 25 | 7.4% | -0.6% | ||
| Q4 24 | 17.2% | -3.9% | ||
| Q3 24 | 6.6% | -1.9% | ||
| Q2 24 | 18.2% | -10.2% | ||
| Q1 24 | 6.8% | 0.2% |
| Q4 25 | $0.66 | $-10.23 | ||
| Q3 25 | $0.58 | $0.05 | ||
| Q2 25 | $0.11 | $-0.06 | ||
| Q1 25 | $0.35 | $-0.05 | ||
| Q4 24 | $0.87 | $-0.32 | ||
| Q3 24 | $0.32 | $-0.15 | ||
| Q2 24 | $0.91 | $-0.79 | ||
| Q1 24 | $0.36 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | — |
| Total DebtLower is stronger | $6.4B | — |
| Stockholders' EquityBook value | $4.0B | $2.9B |
| Total Assets | $13.6B | $8.5B |
| Debt / EquityLower = less leverage | 1.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.1B | $432.1M | ||
| Q2 25 | $1.2B | $454.2M | ||
| Q1 25 | $1.3B | $409.9M | ||
| Q4 24 | $1.1B | $558.8M | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $1.3B | $542.8M | ||
| Q1 24 | $1.1B | $658.5M |
| Q4 25 | $6.4B | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.4B | — | ||
| Q1 25 | $6.4B | — | ||
| Q4 24 | $6.4B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.4B | — | ||
| Q1 24 | $8.4B | — |
| Q4 25 | $4.0B | $2.9B | ||
| Q3 25 | $4.0B | $4.4B | ||
| Q2 25 | $3.9B | $4.5B | ||
| Q1 25 | $4.1B | $4.4B | ||
| Q4 24 | $4.2B | $4.3B | ||
| Q3 24 | $4.1B | $4.6B | ||
| Q2 24 | $4.2B | $4.5B | ||
| Q1 24 | $4.1B | $4.7B |
| Q4 25 | $13.6B | $8.5B | ||
| Q3 25 | $13.5B | $10.1B | ||
| Q2 25 | $13.8B | $10.1B | ||
| Q1 25 | $13.8B | $9.8B | ||
| Q4 24 | $13.7B | $9.6B | ||
| Q3 24 | $13.8B | $11.2B | ||
| Q2 24 | $14.2B | $10.4B | ||
| Q1 24 | $16.4B | $10.6B |
| Q4 25 | 1.58× | — | ||
| Q3 25 | 1.61× | — | ||
| Q2 25 | 1.62× | — | ||
| Q1 25 | 1.55× | — | ||
| Q4 24 | 1.51× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.52× | — | ||
| Q1 24 | 2.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $318.7M | $175.4M |
| Free Cash FlowOCF − Capex | $279.4M | $148.6M |
| FCF MarginFCF / Revenue | 21.1% | 13.4% |
| Capex IntensityCapex / Revenue | 3.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | $878.5M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $318.7M | $175.4M | ||
| Q3 25 | $147.8M | $51.7M | ||
| Q2 25 | $158.2M | $75.9M | ||
| Q1 25 | $402.2M | $-64.5M | ||
| Q4 24 | $348.0M | $312.6M | ||
| Q3 24 | $-77.8M | $42.2M | ||
| Q2 24 | $185.2M | $9.5M | ||
| Q1 24 | $384.7M | $-1.4M |
| Q4 25 | $279.4M | $148.6M | ||
| Q3 25 | $101.2M | $29.8M | ||
| Q2 25 | $124.0M | $56.7M | ||
| Q1 25 | $373.8M | $-90.0M | ||
| Q4 24 | $306.7M | $274.9M | ||
| Q3 24 | $-117.1M | $15.1M | ||
| Q2 24 | $145.2M | $-18.9M | ||
| Q1 24 | $348.2M | $-26.5M |
| Q4 25 | 21.1% | 13.4% | ||
| Q3 25 | 7.9% | 2.9% | ||
| Q2 25 | 9.5% | 5.4% | ||
| Q1 25 | 29.8% | -8.6% | ||
| Q4 24 | 23.0% | 24.2% | ||
| Q3 24 | -9.2% | 1.4% | ||
| Q2 24 | 10.7% | -1.8% | ||
| Q1 24 | 24.1% | -2.4% |
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 3.6% | 2.1% | ||
| Q2 25 | 2.6% | 1.8% | ||
| Q1 25 | 2.3% | 2.4% | ||
| Q4 24 | 3.1% | 3.3% | ||
| Q3 24 | 3.1% | 2.5% | ||
| Q2 24 | 2.9% | 2.7% | ||
| Q1 24 | 2.5% | 2.3% |
| Q4 25 | 1.90× | — | ||
| Q3 25 | 1.01× | 6.89× | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 4.33× | — | ||
| Q4 24 | 1.51× | — | ||
| Q3 24 | -0.92× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 3.91× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OTEX
| Transferred At Point In Time | $184.2M | 14% |
| Cybersecurity Enterprise Product | $174.5M | 13% |
| Business Network Product | $159.8M | 12% |
| Business Network Cloud Services And Subscriptions | $151.4M | 11% |
| Content Cloud Services And Subscriptions | $137.9M | 10% |
| Cybersecurity SMB Consumer Product | $127.6M | 10% |
| Application Delivery Management Product | $120.1M | 9% |
| IT Operations Management Product | $113.3M | 9% |
| Professional Service And Other | $82.5M | 6% |
| Analytics Product | $58.1M | 4% |
| IT Operations Management Cloud Services And Subscriptions | $7.8M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
